Four Different Markers for Activated Cell Mediated Immunity Compared with the Clinical Stages of HIV Infection

Four Different Markers for Activated Cell Mediated Immunity Compared with the Clinical Stages of HIV Infection

Activated cell-mediated immunity, as defined by four markers, has been studied in HIV-infected patients, and compared with the clinical stages of HIV infection. All the values obtained with such markers (interferon-y expressed on lymphocytes, soluble CD8, soluble IL-2 receptor, and serum neopterin)...

Full description

Bibliographic Details
Main Authors:	Caruso Arnaldo, Francesco Maria de, Gonzales Rosanna, Pollara Patrizia, Zanoni Lorenzo, Foresti Ida, Turano Adolfo
Format:	Article
Language:	English
Published:	De Gruyter 1990-01-01
Series:	Pteridines
Online Access:	https://doi.org/10.1515/pteridines.1990.2.1.51

Similar Items

Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
by: Matthew Zirui Tay, et al.
Published: (2019-02-01)

Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study
by: Maria Antonia De Francesco, et al.
Published: (2021-09-01)

Virological, Immune and Host genetics Markers in the Control of HIV Infection
by: Beatriz Mothe, et al.
Published: (2009-01-01)

Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV
by: Sadeer G. Al-Kindi, et al.
Published: (2017-05-01)

Frailty, markers of immune activation and oxidative stress in HIV infected elderly.
by: Susana Álvarez, et al.
Published: (2020-01-01)

Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.
by: Owen Ngalamika, et al.
Published: (2020-01-01)

Markers, Cofactors and Staging Systems in the Study of HIV Disease Progression: A Review
by: MC Portela, et al.
Published: (1997-07-01)

Immune Dysfunction in HIV: A Possible Role for Pro- and Anti-Inflammatory Cytokines in HIV Staging
by: Iorhen Ephraim Akase, et al.
Published: (2017-01-01)

Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.
by: Alinda G Vos, et al.
Published: (2017-01-01)

Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults.
by: Anita S Iyer, et al.
Published: (2016-01-01)

Impact of maraviroc on immune restoration in an advanced stage HIV-infected patient
by: Poizot-Martin Isabelle, et al.
Published: (2010-05-01)

Four-Stage Audit Demonstrating Increased Uptake of HIV Testing in Acute Neurology Admissions Using Staged Practical Interventions.
by: Dilraj Singh Sokhi, et al.
Published: (2015-01-01)

Uniquely altered transcripts are associated with immune preservation in HIV infection.
by: Michelle Zanoni, et al.
Published: (2017-01-01)

Immune activation markers associated with levels and diversity of intact HIV proviruses during HIV- HBV co-infection
by: X.Q. Wang, et al.
Published: (2019-07-01)

Immunological markers of protective immune reconstitution in HIV infected persons sensitised by Mycobacterium tuberculosis
by: Jhilmeet, Nishtha
Published: (2018)

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy
by: Sukrutha Chettimada, et al.
Published: (2018-05-01)

Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
by: Letizia Santinelli, et al.
Published: (2020-05-01)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
by: Alessandra D’Abramo, et al.
Published: (2014-01-01)

Platelet flow cytometry and coagulation tests as markers of immune activation in chronic HIV infection
by: Nkambule, Bongani Brian
Published: (2012)

Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes
by: Nathalia Beatriz Ramos de Sá, et al.
Published: (2020-01-01)

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015-04-01)

Cardiac Steatosis in HIV-A Marker or Mediator of Disease?
by: Morgan Jacob, et al.
Published: (2018-10-01)

Four actors perform on stage.
Published: ()

Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men.
by: F A Tobolowsky, et al.
Published: (2018-01-01)

Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women
by: Sharon M. Anderson, et al.
Published: (2020-10-01)

Monocytes in chronic HIV-1 infection : changes in phenotypic marker expression and their relationship with immune activation
by: Poovan, Karmistha
Published: (2015)

A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer
by: Havjin Jacob, et al.
Published: (2018-04-01)

HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
by: A. V. Mordyk, et al.
Published: (2016-06-01)

Influence of KIR/HLA and FcyRIIIa genotypes on anti-HIV ADCC responses in HIV uninfected and infected slow progressor subjects
by: Zanoni, Pilar
Published: (2013)

Changes of immune function, tumor markers and inflammatory factors in breast cancer patients with different pathological stages
by: Yan-Kui Li
Published: (2019-04-01)

Interferon-γ, a valuable surrogate marker of <it>Plasmodium falciparum </it>pre-erythrocytic stages protective immunity
by: BenMohamed Lbachir, et al.
Published: (2011-02-01)

Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies
by: Terry A. Jacot, et al.
Published: (2018-11-01)

Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
by: Antonio Citro, et al.
Published: (2021-02-01)

Comprehensive assessment of markers of systemic inflammation and activation of immunity in HIV-positive patients receiving antiretroviral therapy
by: A. Matuzkova, et al.
Published: (2020-12-01)

Evaluation of haematological parameters and immune markers in HIV-infected and non-infected pre-eclamptic Black women.
by: Naidoo, Kalendri.
Published: (2010)

Four people on stage at Festival Puertorriqueño.
Published: ()

Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance
by: Manuela Fogli, et al.
Published: (2012-01-01)

Pterins as markers of immune activation
by: Rippin, Julian John
Published: (1995)

Roles of cellular innate immunity and inflammatory markers in the immune reconstitution syndrome observed during co-infection with tuberculosis in HIV infected patients in Cambodia
by: Nouhin, Janin
Published: (2016)

High-throughput single-cell transcriptome analysis of immune cells from HIV-1 infected individuals before and after therapy
by: T. Bradley, et al.
Published: (2017-12-01)